Probiotics for Preventing Necrotizing Enterocolitis: A Meta‐Analysis with Trial Sequential Analysis
Open Access
- 1 January 2023
- journal article
- research article
- Published by Wiley in Journal of Clinical Pharmacy and Therapeutics
- Vol. 2023 (1)
Abstract
What is Known and Objective. The role of probiotics, especially the different genera of probiotics, in managing necrotizing enterocolitis (NEC) is controversial. Thus, we performed a meta‐analysis with trial sequential analysis (TSA) to determine the efficacy and safety of probiotics for preventing NEC. Methods. Medline, Embase, CENTRAL, WorldCat, TROVE, DART‐Europe, and CBM were searched from inception to May 2022. Two investigators independently screened the literature, extracted data, and assessed the quality of the included studies. Meta‐analysis was performed using RevMan 5.4, and TSA was conducted using TSA 0.9 beta. Results and Discussion. Fifty‐five studies involving 12897 newborns were eligible. The use of probiotics for preventing NEC reduced the incidence of NEC (RR 0.48, 95% CI 0.41 to 0.57, and P < 0.05) and sepsis (RR 0.77, 95% CI 0.64 to 0.94, and P < 0.05), the risk of mortality (RR 0.69, 95% CI 0.58 to 0.84, and P < 0.05), and shortened the average days of hospitalization (MD −3.12, 95% CI −4.98 to −1.26, and P < 0.05). However, subgroup analysis revealed that different genera of probiotics gave rise to different outcomes. In addition, TSA indicated that the cumulative z‐curve crossed the traditional and trial sequential monitoring boundaries for benefit, providing firm evidence that multiple strains and Lactobacillus species of probiotics decreased the incidence of NEC. However, the current evidence was inconclusive for Bifidobacterium and Saccharomyces species. What is New and Conclusions. Probiotics are effective in preventing NEC and sepsis and could provide added benefits, including decreasing mortality and the number of days of hospitalization. However, considering the heterogeneity of probiotics regimens and the risk of selective reporting of RCTs, more high‐quality clinical trials targeting different genera of probiotics with suitable doses and timing to prophylactic use of probiotics are needed to avoid overestimating the role of probiotics in preterm infants.Keywords
Funding Information
- Bureau of Science and Technology of Zhoushan (2022C31035)
This publication has 74 references indexed in Scilit:
- Prophylactic Probiotics to Prevent Death and Nosocomial Infection in Preterm InfantsPediatrics, 2012
- Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitisArchives of Disease in Childhood - Fetal and Neonatal Edition, 2012
- Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcomeJournal of Perinatology, 2010
- Retracted Paper - Comparison Between Killed and Living Probiotic Usage Versus Placebo for the Prevention of Necrotizing Enterocolitis and Sepsis in NeonatesPakistan Journal of Biological Sciences, 2010
- Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trialThe American Journal of Clinical Nutrition, 2009
- A Randomized Placebo‐controlled Comparison of 2 Prebiotic/Probiotic Combinations in Preterm Infants: Impact on Weight Gain, Intestinal Microbiota, and Fecal Short‐chain Fatty AcidsJournal of Pediatric Gastroenterology and Nutrition, 2009
- Effects of Bifidobacterium lactis Bb12 Supplementation on Intestinal Microbiota of Preterm Infants: a Double-Blind, Placebo-Controlled, Randomized StudyJournal of Clinical Microbiology, 2006
- Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight NeonatesThe Journal of Pediatrics, 2005
- Enteral feeding of premature infants with Lactobacillus GG.Archives of Disease in Childhood, 1993
- Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infantsThe Pediatric Infectious Disease Journal, 1986